David Bourn
Impact in
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
- Neurology top 5%
- Neurofibromatosis and Schwannoma Cases
- Vascular Malformations Diagnosis and Treatment
Papers in
-
- RNA and protein synthesis mechanisms 4
- RNA modifications and cancer 4
-
- Sarcoma Diagnosis and Treatment 3
- Electrolyte and hormonal disorders 3
- Co-authors
- D. Gareth Evans (4 shared papers)Tom Strachan (3 shared papers)Simon Carter (1 shared paper)T Strachan (3 shared papers)Natalia A. Trayanova (3 shared papers)Julian P. Venables (1 shared paper)Anne E. Hughes (1 shared paper)Michael S. Jackson (1 shared paper)
- Journals
- Human Genetics (3 papers)Human Molecular Genetics (2 papers)The Journal of Laryngology & Otology (2 papers)Cytopathology (1 paper)PLoS Currents (1 paper)
- Partner nations
- United KingdomUnited StatesCzechia
In The Last Decade
David Bourn
35 papers receiving 620 citations
Peers
Comparison fields: 5 of 68
- Nephrology 94
- Neurology 182
- Immunology 180
- Hematology 83
- Physiology 22
Countries citing papers authored by David Bourn
This map shows the geographic impact of David Bourn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bourn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bourn more than expected).
Fields of papers citing papers by David Bourn
This network shows the impact of papers produced by David Bourn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bourn. The network helps show where David Bourn may publish in the future.
Co-authors
The 25 scholars most cited alongside David Bourn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 169 | |
| 2 | 1994 | 83 | |
| 3 | A mutation in the neurofibromatosis type 2 tumor-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals. | 1994 | 58 |
| 4 | 2003 | 39 | |
| 5 | 2014 | 31 | |
| 6 | 1995 | 25 | |
| 7 | 1995 | 23 | |
| 8 | 2009 | 21 | |
| 9 | 2017 | 20 | |
| 10 | 1995 | 19 | |
| 11 | 2018 | 16 | |
| 12 | 2015 | 15 | |
| 13 | 2021 | 12 | |
| 14 | 2011 | 12 | |
| 15 | 2013 | 11 | |
| 16 | 2015 | 10 | |
| 17 | 2006 | 9 | |
| 18 | 1973 | 9 | |
| 19 | 2019 | 8 | |
| 20 | 1991 | 8 |
About David Bourn
David Bourn is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Neurology, Cardiology and Cardiovascular Medicine and Surgery, having authored 35 papers that have together received 634 indexed citations. Recurring topics across this work include Neurofibromatosis and Schwannoma Cases (5 papers), RNA and protein synthesis mechanisms (4 papers), RNA modifications and cancer (4 papers), Sarcoma Diagnosis and Treatment (3 papers), Cardiac electrophysiology and arrhythmias (3 papers), Electrolyte and hormonal disorders (3 papers), Cardiac pacing and defibrillation studies (2 papers) and Neuroblastoma Research and Treatments (2 papers). The work is most often cited by research in Nephrology (94 citations), Neurology (182 citations), Immunology (180 citations), Hematology (83 citations) and Physiology (22 citations). David Bourn has collaborated with scholars based in United Kingdom, United States and Czechia. Frequent co-authors include D. Gareth Evans, Tom Strachan, Simon Carter, T Strachan, Natalia A. Trayanova, Julian P. Venables, Anne E. Hughes, Michael S. Jackson, Katrina Wood and Judith Goodship. Their work appears in journals such as Human Genetics, Human Molecular Genetics, The Journal of Laryngology & Otology, Cytopathology and PLoS Currents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.